Literature DB >> 6351390

Study of chemotherapy regimens of 5 and 7 months' duration and the role of corticosteroids in the treatment of sputum-positive patients with pulmonary tuberculosis in South India.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6351390     DOI： 10.1016/0041-3879(83)90032-6

Source DB:  PubMed          Journal:  Tubercle        ISSN： 0041-3879


× No keyword cloud information.
  13 in total

Review 1.  Advancing host-directed therapy for tuberculosis.

Authors:  Robert S Wallis; Richard Hafner
Journal:  Nat Rev Immunol       Date:  2015-03-13       Impact factor: 53.106

Review 2.  Novel adjunctive therapies for the treatment of tuberculosis.

Authors:  A A Ordonez; M Maiga; S Gupta; E A Weinstein; W R Bishai; S K Jain
Journal:  Curr Mol Med       Date:  2014-03       Impact factor: 2.222

Review 3.  Avoidance and management of adverse reactions to antituberculosis drugs.

Authors:  A M Patel; J McKeon
Journal:  Drug Saf       Date:  1995-01       Impact factor: 5.606

4.  Outcome of standardized treatment for patients with MDR-TB from Tamil Nadu, India.

Authors:  Pauline Joseph; Vijaya Bhaskara Rao Desai; Nalini Sunder Mohan; Jemima Sheila Fredrick; Rajeswari Ramachandran; Balambal Raman; Fraser Wares; Ranjani Ramachandran; Aleyamma Thomas
Journal:  Indian J Med Res       Date:  2011-05       Impact factor: 2.375

5.  Profile and response to anti-tuberculosis treatment among elderly tuberculosis patients treated under the TB Control programme in South India.

Authors:  Banu Rekha Vaithilingam Velayutham; Dina Nair; Vedachalam Chandrasekaran; Balambal Raman; Gomathy Sekar; Basilea Watson; Niruparani Charles; Muniyandi Malaisamy; Aleyamma Thomas; Soumya Swaminathan
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

6.  Corticosteroid effects on sputum culture in pulmonary tuberculosis: a meta-regression analysis.

Authors:  Robert S Wallis
Journal:  Open Forum Infect Dis       Date:  2014-06-03       Impact factor: 3.835

Review 7.  Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis.

Authors:  Dick Menzies; Andrea Benedetti; Anita Paydar; Ian Martin; Sarah Royce; Madhukar Pai; Andrew Vernon; Christian Lienhardt; William Burman
Journal:  PLoS Med       Date:  2009-09-15       Impact factor: 11.069

Review 8.  Corticosteroids as an adjunct to tuberculosis therapy.

Authors:  Charlotte Schutz; Angharad G Davis; Bianca Sossen; Rachel P-J Lai; Mpiko Ntsekhe; Yolande Xr Harley; Robert J Wilkinson
Journal:  Expert Rev Respir Med       Date:  2018-09-06       Impact factor: 3.772

9.  Randomized clinical trial of thrice-weekly 4-month moxifloxacin or gatifloxacin containing regimens in the treatment of new sputum positive pulmonary tuberculosis patients.

Authors:  Mohideen S Jawahar; Vaithilingam V Banurekha; Chinnampedu N Paramasivan; Fathima Rahman; Rajeswari Ramachandran; Perumal Venkatesan; Rani Balasubramanian; Nagamiah Selvakumar; Chinnaiyan Ponnuraja; Allaudeen S Iliayas; Navaneethapandian P Gangadevi; Balambal Raman; Dhanaraj Baskaran; Santhanakrishnan R Kumar; Marimuthu M Kumar; Victor Mohan; Sudha Ganapathy; Vanaja Kumar; Geetha Shanmugam; Niruparani Charles; Murugesan R Sakthivel; Kannivelu Jagannath; Chockalingam Chandrasekar; Ramavaram T Parthasarathy; Paranji R Narayanan
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

Review 10.  What are the most efficacious treatment regimens for isoniazid-resistant tuberculosis? A systematic review and network meta-analysis.

Authors:  H R Stagg; R J Harris; H-A Hatherell; D Obach; H Zhao; N Tsuchiya; K Kranzer; V Nikolayevskyy; J Kim; M C Lipman; I Abubakar
Journal:  Thorax       Date:  2016-06-13       Impact factor: 9.139
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.